Morrison Foerster

We are only able to display limited information for this firm. We display more complete information for all of the following firms:

Reputed for its technology expertise, Morrison Foerster is frequently sought out by biotechnology innovators for its expertise in licensing, venture capital and commercialisation. Other areas of expertise include IP protection, acquisitions, dispute resolution and compliance. The practice is led by seasoned trio Chuan Sun, Gordon Milner and Janet Xiao. Shanghai’s managing partner Sun is particularly adept in complex corporate and commercial transactions intersecting life sciences and technology, as well as cross-border data transfers and regulations. Milner splits his time between Hong Kong and Singapore and is equipped to handle pharmaceutical and biotechnology cross-border data transfers and IP matters. Xiao is reputed for IP advisory, particularly US and China cross-border transactions and operations, assessing risks and due diligence, with extensive experience in cancer immunotherapy, gene editing and antibody manufacturing patent issues.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • The team has strong industry expertise and demonstrated a deep understanding of the complexities involved in healthcare M&A, particularly when working with global industry leaders. This transaction required both top-tier M&A execution and sector-specific healthcare knowledge. The firm's M&A and healthcare partners collaborated seamlessly to provide comprehensive, specialised support across all aspects of the deal.'
  • 'I was particularly impressed by their pragmatic and results-oriented negotiation style. By striking the right balance between firm advocacy and strategic flexibility, the team helped us achieve our key commercial goals without delaying the timeline. Their commercial acumen helped to reach consensus on critical terms while maintaining a constructive, solution-focused dialogue.'

Key clients

  • OcuMension Therapeutics
  • Ally Bridge Group